Pharmacogenomics: From Precision Medicine to Precision Public Health

Print
Related Pages

October 7, 2021, 11:00 am -12:00 pm EDT

Please join this free Zoom seminar

Advances in pharmacogenomics continue to occur at a rapid pace and promise a new era of personalized interventions for disease treatment and prevention.  In this seminar, we explore the evolution of the field from basic science discoveries to clinical and population health applications. Our speakers come from the University of Florida Precision Health Program where a number of research initiatives continue to provide an emerging evidentiary foundation for using pharmacogenomics to improve population health.

Sonja A. Rasmussen

Sonja A. Rasmussen, MD, MS,
Professor
College of Medicine & College of Public Health and Health Professions
University of Florida

Introduction to Precision Health
Julie A. Johnson

Julie A. Johnson, PharmD
Dean and Distinguished Professor
College of Pharmacy
University of Florida

Pharmacogenomics Discovery, Clinical Implementation and Outcomes Documentation
Julio D. Duarte

Julio D. Duarte PharmD, PhD
Assistant Professor
College of Pharmacy
University of Florida

Identifying Medically Underserved Populations Most Likely to Benefit from Pharmacogenomic Testing

Selected References

  1. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther, 2013
  2. Clinical pharmacogenetics implementation: approaches, successes, and challenges. Am J Med Genet C Semin Med Genet, 2014
  3. Multisite investigation of outcomes with implementation of CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention. JACC Cardiovasc Interv, 2018
  4. Patients with geographic barriers to health care access are prescribed a higher proportion of drugs with pharmacogenetic testing guidelines. Clinical and Translational Science, 2021

Hosted by

  • Office of Genomics and Precision Public Health, Office of Science